Prytime Medical

Executive Summary

Prytime Medical Devices, Inc. is a Texas-based medical device company specializing in minimally invasive solutions for hemorrhage control and resuscitation. Its flagship product, the ER-REBOA™ catheter system, enables Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) to manage non-compressible truncal hemorrhage, a leading cause of death in trauma and military settings. Founded in 2010, the company targets emergency medicine and military markets, addressing a critical unmet need for rapid, effective bleeding control in pre-hospital and hospital environments. The device has gained traction in both civilian trauma centers and military applications, offering a life-saving alternative to open surgery. Prytime Medical operates in a niche but growing segment of the medical device industry, with the global REBOA market expected to expand due to increasing trauma incidence and military modernization. The company's competitive advantage lies in its proprietary catheter design, which simplifies deployment and reduces complications compared to earlier REBOA devices. With existing commercial adoption and ongoing clinical evidence generation, Prytime is well-positioned for growth. However, it faces competition from larger device manufacturers and alternative hemorrhage control technologies. Key future drivers include broader FDA indications, integration into trauma protocols, and potential defense contracts. The company's private status limits public financial visibility, but its focus on a high-mortality condition suggests significant market potential.

Upcoming Catalysts (preview)

• TBDFDA clearance for expanded indication (e.g., pediatric or pre-hospital use)70% success
• TBDMajor contract award from U.S. Department of Defense or allied military60% success
• TBDPublication of pivotal clinical trial data supporting improved survival outcomes80% success